← Eichor
Study identifier: NCT05877391 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Intervention to Collect and Utilize Sexual Orientation and Gender Identity (SOGI) Information in Hospice

Condition: Sexual and Gender Minorities · Hospice · Alzheimer's Disease and Related Dementias  ·  Sponsor: University of Colorado, Denver

PhaseNA
Planned participants80
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersYes

About this study

Older sexual and gender minority (SGM) patients are at risk for receiving inequitable end-of-life care; those with Alzheimer's disease and related dementias (ADRD) are at particularly high risk. Failure to collect and integrate sexual orientation and gender identity (SOGI) data to identify patients' informal support systems may have adverse health consequences for SGM older adults, particularly for those dependent on informal caregivers to provide in-home support and assist with activities of daily living. The goal of this K01 is develop a novel training for hospice staff in person-centered communication that includes SOGI data collection to promote authentic end-of-life care for SGM patients and their caregivers.

This description comes directly from the study's public registry record.

Talk to the study team

Carey Candrian, PhD  ·  3037247892  ·  carey.candrian@cuanschutz.edu

Always discuss trial participation with your own doctor first.

Locations (1)

University of ColoradoAurora, Colorado, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05877391